Back
Intra-Cellular Therapies Quote, Financials, Valuation and Earnings
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
26
ITCI
Intra-Cellular Therapies
Last Price:
77.06
Seasonality Move:
-4.41%
7 Day Trial
ALL ACCESS PASS
$
7
Hint at where the next big move in the market will be this month
Spot the next big move with this free book from a hedge fund managerIntra-Cellular Therapies Price Quote
$77.06
+0.09 (+3.19%)
(Updated: September 20, 2024 at 6:19 AM ET)
Intra-Cellular Therapies Key Stats
Sell
26
Intra-Cellular Therapies (ITCI)
is a Sell
Day range:
$74.62 - $77.18
52-week range:
$45.50 - $84.89
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
13.42
P/B ratio:
7.11%
Volume:
544.3K
Avg. volume:
487.6K
1-year change:
41.59%
Market cap:
$8.1B
Revenue:
$462.2M
EPS:
$-0.87
How Much Does Intra-Cellular Therapies Make?
-
How Much Are Intra-Cellular Therapies's Sales Annually?
ITCI Revenues are $462.2M -
How Much Profit Does Intra-Cellular Therapies's Make A Year?
ITCI net income is -$139.7M
Is Intra-Cellular Therapies Growing As A Company?
-
What Is Intra-Cellular Therapies's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.46% -
What Is Intra-Cellular Therapies's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Intra-Cellular Therapies Stock Price Performance
-
Did Intra-Cellular Therapies Stock Go Up Last Month?
Intra-Cellular Therapies share price went up by 1.64% last month -
Did ITCI's Share Price Rise Over The Last Year?
ITCI share price rose by 41.59% over the past 1 year
What Is Intra-Cellular Therapies 52-Week High & Low?
-
What Is Intra-Cellular Therapies’s 52-Week High Share Price?
Intra-Cellular Therapies has traded as high as $84.89 over the past 52 weeks -
What Is Intra-Cellular Therapies’s 52-Week Low Share Price?
Intra-Cellular Therapies has traded as low as $45.50 over the past 52 weeks
Intra-Cellular Therapies Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Intra-Cellular Therapies?
-
How Much Debt Does Intra-Cellular Therapies Have?
Total long term debt quarterly is $0 -
How Much Cash Does Intra-Cellular Therapies Have?
Cash and short term investments quarterly total is $1B -
What Is Intra-Cellular Therapies’s Book Value Per Share?
Book value per share is 10.84
Is Intra-Cellular Therapies Cash Flow Positive?
-
What Is ITCI Cash Flow From Operations?
Cash flow from operations (TTM) is -$60.9M -
What Is Intra-Cellular Therapies’s Cash Flow From Financing?
Cash flow from financing (TTM) is $560.8M -
What Is Intra-Cellular Therapies’s Cash Flow From Investing?
Cash flow from investing (TTM) is $51.2M
Intra-Cellular Therapies Return On Invested Capital
-
Is Management Doing A Good Job?
ITCI return on invested capital is -11.9% -
What Is Intra-Cellular Therapies Return On Assets?
ROA measures how assets are converting to revenues and is -9.97% -
What Is ITCI Return On Equity?
ROE is a measure of profitability and is -11.9%
Intra-Cellular Therapies Earnings Date & Stock Price
-
What Is Intra-Cellular Therapies's Stock Price Today?
A single share of ITCI can be purchased today for 76.97 -
What Is Intra-Cellular Therapies’s Stock Symbol?
Intra-Cellular Therapies trades on the nasdaq under the ticker symbol: ITCI -
When Is Intra-Cellular Therapies’s Next Earnings Date?
The next quarterly earnings date for Intra-Cellular Therapies is scheduled on November 1, 2024 -
When Is ITCI's next ex-dividend date?
Intra-Cellular Therapies's next ex-dividend date is May 26, 2020 -
How To Buy Intra-Cellular Therapies Stock?
You can buy Intra-Cellular Therapies shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Intra-Cellular Therapies Competitors
-
Who Are Intra-Cellular Therapies's Competitors?
Below is a list of companies who compete with Intra-Cellular Therapies or are related in some way:
Intra-Cellular Therapies Dividend Yield
-
What Is ITCI Dividend Yield?
Intra-Cellular Therapies’s dividend yield currently is 0% -
What Is Intra-Cellular Therapies’s Payout Ratio?
Intra-Cellular Therapies’s payout ratio is 0% -
When Did Intra-Cellular Therapies Last Pay A Dividend?
The latest dividend pay date is September 20, 2024 -
What Is Intra-Cellular Therapies’s Dividend Per Share?
Intra-Cellular Therapies pays a dividend of $0.00 per share
Intra-Cellular Therapies Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 13.2% |
| Revenue: | 46.44% | 2.22% |
Analyst Recommendations
| Buy Recommendations: | 9 |
|---|---|
| Hold Recommendations: | 2 |
| Sell Recommendations: | 0 |
| Price Target: | 96.13 |
| Upside from Last Price: | 24.9% |